Condition
Continuous Glucose Monitoring System
Total Trials
5
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Not Yet Recruiting2
Enrolling By Invitation1
Completed1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07544368Not ApplicableNot Yet Recruiting
Mediterranean Diet and Oxidative Stress in Type 1 Diabetes (MEDOX-T1D)
NCT06904846Not ApplicableEnrolling By Invitation
To Evaluate the Change in Glucose Parameters in Adult Patients With Type 1 or Type 2 Diabetes From Europe Using the iCan o3 CGM System for 60 Days Period
NCT07184775Not ApplicableRecruiting
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
NCT06899503Not Yet Recruiting
Creating Linked Inpatient CGM for Kids
NCT03120091CompletedPrimary
Assessment of the Accuracy,Feasibility,Safety of Continuous Glucose Monitoring System
Showing all 5 trials